ATE241978T1 - Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen - Google Patents

Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen

Info

Publication number
ATE241978T1
ATE241978T1 AT97112930T AT97112930T ATE241978T1 AT E241978 T1 ATE241978 T1 AT E241978T1 AT 97112930 T AT97112930 T AT 97112930T AT 97112930 T AT97112930 T AT 97112930T AT E241978 T1 ATE241978 T1 AT E241978T1
Authority
AT
Austria
Prior art keywords
sup
dioxabicyclo
octane
methoxy
methylenedioxyphenyl
Prior art date
Application number
AT97112930T
Other languages
English (en)
Inventor
Yoshifumi Shinmen
Kengo Akimoto
Sumio Asami
Yoshihide Suwa
Yoshinori Kitagawa
Michihiro Sugano
Hideaki Yamada
Sakayu Shimizu
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1187497A external-priority patent/JP3001589B2/ja
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE241978T1 publication Critical patent/ATE241978T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056Spread compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60Salad dressings; Mayonnaise; Ketchup
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Finger-Pressure Massage (AREA)
  • Fats And Perfumes (AREA)
AT97112930T 1989-07-21 1990-07-20 Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen ATE241978T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1187497A JP3001589B2 (ja) 1989-07-21 1989-07-21 リグナン類含有飲食物
JP8750090 1990-04-03

Publications (1)

Publication Number Publication Date
ATE241978T1 true ATE241978T1 (de) 2003-06-15

Family

ID=26428763

Family Applications (3)

Application Number Title Priority Date Filing Date
AT90307978T ATE208195T1 (de) 1989-07-21 1990-07-20 Mittel zur verbesserung der leberfunktion
AT97112931T ATE285765T1 (de) 1989-07-21 1990-07-20 Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan
AT97112930T ATE241978T1 (de) 1989-07-21 1990-07-20 Therapeutische anwendung von dioxabicyclo(3.3.0)oktan-verbindungen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT90307978T ATE208195T1 (de) 1989-07-21 1990-07-20 Mittel zur verbesserung der leberfunktion
AT97112931T ATE285765T1 (de) 1989-07-21 1990-07-20 Kapsel, enthaltend ein dioxabicyclo(3.3.0)oktan

Country Status (8)

Country Link
US (1) US5180588A (de)
EP (3) EP0818196B1 (de)
AT (3) ATE208195T1 (de)
CA (2) CA2021714C (de)
DE (3) DE69034181T2 (de)
DK (3) DK0409654T3 (de)
ES (3) ES2195058T3 (de)
SG (1) SG42967A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3183664B2 (ja) * 1990-10-22 2001-07-09 サントリー株式会社 コレステロール及び胆汁酸の代謝阻害剤
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
US20020031563A1 (en) * 1992-09-30 2002-03-14 Hodge Thomas W. Method of inhibiting tumor necrosis factor
US5397778A (en) * 1994-02-25 1995-03-14 New England Deaconess Hospital Corporation Enteral formulations for treatment of inflammation and infection
JPH10500937A (ja) * 1994-02-25 1998-01-27 ニュー イングランド ディーコネス ホスピタル コーポレイション セサミン系リグナンの抗炎症及び感染防護効果
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
KR970705345A (ko) * 1995-07-04 1997-10-09 도리이 신이치로 오메가 6계ㆍ오메가 3계 불포화 지방산의 밸런스 조절제를 배합하여 이루어진 식품 조성물(Food composition containing balancing agent for ω- 6 and ω- 3 unsaturated fatty acids)
FR2738828B1 (fr) * 1995-09-20 1997-10-17 Commissariat Energie Atomique Utilisation de cyclodextrines naturelles et de leurs derives pour la solubilisation d'agents anti-agregants plaquettaires de la famille des ginkgolides
US5993795A (en) * 1995-11-09 1999-11-30 Takemoto Yushi Kabushiki Kaisha Protein composition derived from sesame seed and use thereof
US5811313A (en) * 1997-06-17 1998-09-22 King Pharmaceuticals, Inc. Identification test for highly refined sesame oil
KR20040058192A (ko) * 2001-10-19 2004-07-03 맥심 파마수티컬즈 인크. 간 질환 치료용으로서의 히스타민 용도
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
FI114917B (fi) * 2002-08-29 2005-01-31 Hormos Nutraceutical Oy Ltd Lignaanikomplekseja
CA2592532C (en) * 2004-12-28 2015-02-17 Suntory Limited Sesamin/episesamin compositions with improved bioavailability
ES2375115T3 (es) * 2005-03-31 2012-02-24 Suntory Holdings Limited Emulsión de aceite en agua que contiene un compuesto de lignano y composición que comprenden al mismo.
EP1930333B1 (de) 2005-09-30 2014-11-05 Suntory Holdings Limited Verfahren und vorrichtung zur herstellung einer an episesamin reichen zusammensetzung
WO2007119378A1 (ja) * 2006-03-15 2007-10-25 Suntory Limited リボフラビンとセサミン類とを含有する組成物
JP5069416B2 (ja) * 2006-03-15 2012-11-07 サントリーホールディングス株式会社 吸湿性の改善された飲食品用組成物
EP2002832A4 (de) 2006-03-31 2009-11-11 Suntory Holdings Ltd Zusammensetzung mit einer lignan-verbindung
AU2008239318B2 (en) * 2007-03-15 2013-10-03 Suntory Holdings Limited Anti-fatigue agent
WO2009038090A1 (ja) * 2007-09-19 2009-03-26 Suntory Holdings Limited セサミン類とアラキドン酸類を含有する組成物
SG10201510301UA (en) * 2007-09-19 2016-01-28 Suntory Holdings Ltd Compositions incorporating sesamin-class compounds and vitamin b1 class compounds
JP6156795B2 (ja) * 2013-07-05 2017-07-05 公立大学法人大阪市立大学 脂肪細胞分化の抑制用、脂肪細胞の脂肪蓄積量低減用および/または脂肪細胞のアディポネクチン分泌促進用組成物
CN104804012B (zh) * 2015-04-24 2017-06-30 沈阳药科大学 一种具有抗耐药菌活性的化合物止泻木脂素a及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427694A (en) * 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
US4904694A (en) * 1986-06-13 1990-02-27 Tsumura & Co. Biphenyl derivative useful in the treatment of liver diseases
JPH01135892A (ja) * 1987-11-20 1989-05-29 Kuki Sangyo Kk 抗酸化性物質の製造方法
US4868207A (en) * 1988-07-28 1989-09-19 Taisho Pharmaceutical Co., Ltd. Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上5▼―不飽和化酵素阻害剤
JPH02255616A (ja) * 1989-03-27 1990-10-16 Rooman Kogyo:Kk 肝臓疾患用剤

Also Published As

Publication number Publication date
ES2195058T3 (es) 2003-12-01
DK0826369T3 (da) 2003-09-29
US5180588A (en) 1993-01-19
DE69034084D1 (de) 2003-07-10
CA2021714A1 (en) 1991-01-22
EP0409654A3 (en) 1992-05-27
ES2235205T3 (es) 2005-07-01
EP0818196B1 (de) 2004-12-29
DK0409654T3 (da) 2001-12-27
ES2161680T3 (es) 2001-12-16
ATE208195T1 (de) 2001-11-15
DE69033848D1 (de) 2001-12-13
EP0409654A2 (de) 1991-01-23
CA2172855C (en) 2000-02-15
DE69034084T2 (de) 2003-12-04
EP0409654B1 (de) 2001-11-07
EP0818196A1 (de) 1998-01-14
EP0826369B1 (de) 2003-06-04
DE69033848T2 (de) 2002-04-04
SG42967A1 (en) 1997-10-17
DE69034181D1 (de) 2005-02-03
ATE285765T1 (de) 2005-01-15
EP0826369A1 (de) 1998-03-04
DE69034181T2 (de) 2006-01-26
CA2172855A1 (en) 1991-01-22
CA2021714C (en) 1996-07-23
DK0818196T3 (da) 2005-05-02

Similar Documents

Publication Publication Date Title
DE69034084D1 (de) Therapeutische Anwendung von Dioxabicyclo(3.3.0)oktan-Verbindungen
DE69019565D1 (de) Arzneimittel zur Behandlung von Thromben, Entzündungen und hohem Blutdruck.
IL77452A (en) Derivatives of arylcyclobutylalkyl-amines,their preparation and pharmaceutical compositions containing them
EP0340754A3 (de) Monopersulfate von Amino-(poly)percarbonsäuren
DE69230958D1 (de) Arzneizusammensetzung auf Basis von Dioxabicyclo[3.3.0]octanderivaten
JPS5798545A (en) Acetal resin composition
EP0488513A3 (de) Verwendung von Dioxabicyclo [3.3.0]octane Derivaten zur Herstellung eines Arzneimittels zur Hemmung des Cholesterinmetabolismus.
WO1999030722A8 (en) Pharmaceutical compositions for mucolysis and treatment of inflammation
EP0681788A3 (de) Dioxabicyclo 3.3.0 octan-Derivate, z.B. Sesamin etc., zur Vorbeugung und Erleichterung von Allergiesymptomen
IL78273A0 (en) (4.2.0)bicyclooctane derivatives,their preparation and pharmaceutical compositions containing them
ATE21695T1 (de) Aminocyclopentanester, ihre herstellung und pharmazeutische formulierungen.
DE3579345D1 (de) Medizinische oelbaeder.
FI912269A0 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
JPS5436255A (en) Novel sesquiterpene analogue, its preparation, and pharmatheutical containing the same
JPS5323997A (en) Imidazoquinazoline derivatives and their preparation
EP0304842A3 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel
IE900218L (en) Benzopyran derivatives
JPS5328177A (en) Optical active piperidine derivatives and their preparation
JPS5325554A (en) 2-omega,omega-bis(alkyulthio)-or omega,omega(alkylenedithio)-alkyl-5-methylfuran and their preparation
JPS5325514A (en) Omega,omega-bis(alkylthio)-or omega,omega-(alkylenedithio)-2,5-dioxoalkane and its preparation
JPS53124241A (en) Methylenomycin a derivatives and their preparation
HUT58742A (en) Process for producing alpha-adrenerg-receptor antagonistic thieno-benzazepines and pharmaceutical compositions containing them
JPS53137970A (en) Sterylglucoside acetal derivatives
SU1513867A1 (ru) 2,2'-азобис{2-циано-5-[6-или(4-метил-3)(2,3-эпоксипропоксикарбамино)гексил - или (фенил)аминокарбокси]пентаны} в качестве промежуточных продуктов для получения эпоксидных олигомеров
JPS56122372A (en) Prostaglandin i2 derivative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0826369

Country of ref document: EP

EELA Cancelled due to lapse of time